Full Text Journal Articles by
Author Patrick Peeters

Advertisement

Find full text journal articles






Assessment of 5-Year Mortality Outcomes for Femoropoliteal Interventions Using Drug-Eluting Devices in the REAL-PTX Study.

Tim Wittig, Thomas Zeller, Marc Bosiers, Patrick Peeters, Steffen Brucks, Yvonne Bausback, Andrej Schmidt, Dierk Scheinert, Sabine Steiner,

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2021, 14(10):1165-1168]

Cited: 0 times

View full text PDF listing >>



5-Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients.

Lissa Pipeleers, Daniel Abramowicz, Nilufer Broeders, Alain Lemoine, Patrick Peeters, Steven Van Laecke, Laurent E Weekers, Jacques Sennesael, Karl M Wissing, Caroline Geers, Jean-Louis Bosmans,

Withdrawal of either steroids or calcineurin inhibitors are two strategies to reduce treatment-related side effects and improve long-term outcomes of kidney transplantation. The CISTCERT study compared the efficacy and safety of these two strategies. In this multicenter, randomized controlled trial, 151 incident kidney transplant recipients received cyclosporine (CsA), mycophenolic acid ... Read more >>

Transpl Int (Transplant international : official journal of the European Society for Organ Transplantation)
[2021, 34(2):313-326]

Cited: 0 times

View full text PDF listing >>



Advertisement

Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.

Koen Deloose, Marc Bosiers, Patrick Peeters, Jürgen Verbist, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Hendriks, Patrick Lauwers, Jeroen Wauters, Merel Verschueren,

<h4>Purpose</h4>To report the outcomes after treating stenotic or occluded femoropopliteal lesions with a drug-coated balloon (DCB) followed by the implantation of a thin-strut self-expanding bare metal stent in the BIOLUX 4EVER trial (<i>ClinicalTrials.gov</i> identifier NCT02211664).<h4>Materials and methods</h4>The prospective, multicenter, physician-initiated BIOLUX 4-EVER trial was conducted at 5 centers in Belgium ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2020, 27(6):936-945]

Cited: 0 times

View full text PDF listing >>



Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.

Giovanni Torsello, Konstantinos Stavroulakis, Marianne Brodmann, Antonio Micari, Gunnar Tepe, Pierfrancesco Veroux, Andrew Benko, Donghoon Choi, Frank E G Vermassen, Michael R Jaff, Jia Guo, Reka Dobranszki, Thomas Zeller, ,

<b>Purpose:</b> To report the 36-month outcomes from the prospective, multicenter, single-arm IN.PACT Global Study (<i>ClinicalTrials.gov</i> identifier NCT01609296) evaluating the performance of the IN.PACT Admiral drug-coated balloon (DCB) in real-world patients with femoropopliteal occlusive disease. <b>Materials and Methods:</b> The IN.PACT Global Study was conducted at 64 international sites and enrolled 1535 ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2020, 27(5):693-705]

Cited: 5 times

View full text PDF listing >>



WITHDRAWN: Impact on Delayed Graft Function of the Renal Resistive Index in the Immediate Postoperative Period After Kidney Transplantation: A Cohort Analysis.

Stijn Bogaert, Patrick Peeters, Nicole Suchonos, Alexander Decruyenaere, Philippe Decruyenaere, Frank Vermassen, Eric Aj Hoste,

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal. ... Read more >>

Transplant Proc (Transplantation proceedings)
[2020, :]

Cited: 0 times

View full text PDF listing >>



The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.

Thomas Zeller, Antonio Micari, Dierk Scheinert, Iris Baumgartner, Marc Bosiers, Frank E G Vermassen, Martin Banyai, Mehdi H Shishehbor, Hong Wang, Marianne Brodmann, ,

<h4>Objectives</h4>The goal of this study was to evaluate the 5-year follow-up data of the IN.PACT DEEP (Randomized IN.PACT Amphirion Drug-Coated Balloon [DCB] vs. Standard Percutaneous Transluminal Angioplasty [PTA] for the Treatment of Below-the-Knee Critical Limb Ischemia [CLI]) trial.<h4>Background</h4>Initial studies from randomized controlled trials have shown comparable short-term outcomes of DCB ... Read more >>

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2020, 13(4):431-443]

Cited: 3 times

View full text PDF listing >>



Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism.

Michael D Dake, Timothy P Murphy, Albrecht H Krämer, Michael D Darcy, Luke E Sewall, Michael A Curi, Matthew S Johnson, Frank Arena, James L Swischuk, Gary M Ansel, Mitchell J Silver, Souheil Saddekni, Jayson S Brower, Robert Mendes, ,

<h4>Purpose</h4>To report final 2-year outcomes with the Sentry bioconvertible inferior vena cava (IVC) filter in patients requiring temporary protection against pulmonary embolism (PE).<h4>Materials and methods</h4>In a prospective multicenter trial, the Sentry filter was implanted in 129 patients with documented deep vein thrombosis (DVT) and/or PE (67.5%) or who were at ... Read more >>

J Vasc Interv Radiol (Journal of vascular and interventional radiology : JVIR)
[2020, 31(2):221-230.e3]

Cited: 0 times

View full text PDF listing >>



Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE Global Registry and the EVAR-1 clinical trial.

Dittmar Böckler, Adam H Power, Lee H Bouwman, Steven van Sterkenburg, Marc Bosiers, Patrick Peeters, Joep A Teijink, Hence J Verhagen, ,

<h4>Background</h4>The outcomes from the randomized controlled trials (RCTs) comparing endovascular aortic aneurysm repair (EVAR) to open surgical repair (OSR) may no longer be reflective of currently technology. Here the EVAR-1 trial and the ENGAGE registry are examined to assess potential improvements in outcomes with modern stent graft systems.<h4>Methods</h4>EVAR-1 was a ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(5):604-609]

Cited: 0 times

View full text PDF listing >>



Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data.

Martijn L Dijkstra, Clark J Zeebregts, Hence J M Verhagen, Joep A W Teijink, Adam H Power, Dittmar Bockler, Patrick Peeters, Vicente Riambau, Jean-Pierre Becquemin, Michel M P J Reijnen, ,

<h4>Objective</h4>The purpose of this study was to report the incidence, natural history, and outcome of type II endoleaks in the largest prospective real-world cohort to date.<h4>Methods</h4>Patients were extracted from the prospective Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE). Two groups were analyzed: first, patients with an isolated type ... Read more >>

J Vasc Surg (Journal of vascular surgery)
[2020, 71(3):780-789]

Cited: 0 times

View full text PDF listing >>



Editor's Choice - Five Year Outcomes of the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair in the ENGAGE Registry.

Joep A W Teijink, Adam H Power, Dittmar Böckler, Patrick Peeters, Steven van Sterkenburg, Lee H Bouwman, Hence J Verhagen, Marc Bosiers, Vincente Riambau, Jean-Pierre Becquemin, Philippe Cuypers, Marc van Sambeek,

<h4>Objective/background</h4>Endovascular abdominal aortic aneurysm repair (EVAR) is commonly used to treat abdominal aortic aneurysm (AAA). However, the incidence of long-term complications and the need for re-interventions after EVAR remain a concern. Newer generation stent grafts have encouraging short and mid-term outcomes, but thorough analysis of their long-term performance is necessary.<h4>Methods</h4>The ... Read more >>

Eur J Vasc Endovasc Surg (European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery)
[2019, 58(2):175-181]

Cited: 4 times

View full text PDF listing >>



Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.

Yvonne Bausback, Tim Wittig, Andrej Schmidt, Thomas Zeller, Marc Bosiers, Patrick Peeters, Steffen Brucks, Aaron E Lottes, Dierk Scheinert, Sabine Steiner,

<h4>Background</h4>Randomized trials of drug-eluting stents (DES) and drug-coated balloons (DCB) for femoropopliteal interventions reported superior patency rates for both strategies compared to standard balloon angioplasty. To date, head-to-head comparisons are missing.<h4>Objectives</h4>The authors sought to compare DES versus DCB for femoropopliteal lesions through 36 months.<h4>Methods</h4>Within a multicenter, randomized trial, 150 patients with ... Read more >>

J Am Coll Cardiol (Journal of the American College of Cardiology)
[2019, 73(6):667-679]

Cited: 4 times

View full text PDF listing >>



Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain.

Thomas Zeller, Marianne Brodmann, Antonio Micari, Koen Keirse, Patrick Peeters, Gunnar Tepe, Dierk Scheinert, Michael R Jaff, Krishna J Rocha-Singh, Pei Li, Randy Schmahl, Gary M Ansel, ,

Circ Cardiovasc Interv (Circulation. Cardiovascular interventions)
[2019, 12(1):e007730]

Cited: 1 time

View full text PDF listing >>



EVOLUTION Study: 12-month results.

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Jürgen Verbist, Wouter van den Eynde, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Wauters,

BACKGROUND:The EVOLUTION Study is a prospective, non-randomized study, investigating the iVolution stent (iVascular, Barcelona, Spain). The study was conducted at the vascular departments of four hospitals in Belgium. This manuscript reports the findings up to 12-month follow-up time for the total cohort. The primary endpoint of the study is primary ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2019, 60(4):490-495]

Cited: 1 time

View full text PDF listing >>



Evaluation of a new dual-layer micromesh stent system for the carotid artery: 12-month results from the CLEAR-ROAD study.

Marc Bosiers, Koen Deloose, Giovanni Torsello, Dierk Scheinert, Lieven Maene, Patrick Peeters, Stefan Müller-Hülsbeck, Horst Sievert, Ralf Langhoff, Joren Callaert, Carlo Setacci, Jeroen Wauters,

EuroIntervention (EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology)
[2018, 14(10):1144-1146]

Cited: 1 time

View full text PDF listing >>



Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease.

Dierk Scheinert, Antonio Micari, Marianne Brodmann, Gunnar Tepe, Patrick Peeters, Michael R Jaff, Hong Wang, Randy Schmahl, Thomas Zeller, ,

Background The IN.PACT Global Study was an international prospective single-arm clinical trial to evaluate the safety and effectiveness of a drug-coated balloon in the treatment of atherosclerotic disease of the superficial femoral and/or popliteal arteries (P1-P3) in subjects with intermittent claudication and/or rest pain. Prespecified subjects were selected for core-laboratory-adjudicated ... Read more >>

Circ Cardiovasc Interv (Circulation. Cardiovascular interventions)
[2018, 11(10):e005654]

Cited: 6 times

View full text PDF listing >>



Endovascular treatment of a primary aortoduodenal fistula.

Anthony De Smet, Wouter van den Eynde, Patrick Peeters, Jürgen Verbist,

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2018, 59(6):844-845]

Cited: 0 times

View full text PDF listing >>



One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter.

Michael D Dake, Timothy P Murphy, Albrecht H Krämer, Michael D Darcy, Luke E Sewall, Michael A Curi, Matthew S Johnson, Frank Arena, James L Swischuk, Gary M Ansel, Mitchell J Silver, Souheil Saddekni, Jayson S Brower, Robert Mendes, ,

<h4>Purpose</h4>To prospectively assess the Sentry bioconvertible inferior vena cava (IVC) filter in patients requiring temporary protection against pulmonary embolism (PE).<h4>Materials and methods</h4>At 23 sites, 129 patients with documented deep vein thrombosis (DVT) or PE, or at temporary risk of developing DVT or PE, unable to use anticoagulation were enrolled. The ... Read more >>

J Vasc Interv Radiol (Journal of vascular and interventional radiology : JVIR)
[2018, 29(10):1350-1361.e4]

Cited: 1 time

View full text PDF listing >>



How to compare results from open with endovascular procedures?

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Jeroen Wauters,

BACKGROUND:According to the guidelines, bypass surgery is still the golden standard treatment in patients with femoropopliteal TASC C and D lesions and life-style limiting claudication or critical limb ischemia. Over the past few decades, endovascular therapy has made great advancements. However, the success rates of surgical and endovascular procedures cannot ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(2):196-199]

Cited: 0 times

View full text PDF listing >>



The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study.

Liesbeth Daniëls, Maarten Naesens, Jean-Louis Bosmans, Daniel Abramowicz, Evi Nagler, Steven Van Laecke, Patrick Peeters, Dirk Kuypers, Marie-Paule Emonds,

Since the advent of kidney transplantation a key strategy for maximising graft survival by avoiding allorecognition has been to minimise HLA mismatching between donor and recipient. As HLA antibodies are now recognised as being specific for epitopes and donor-recipient HLA mismatch at the amino acid level can now be determined, ... Read more >>

Transpl Immunol (Transplant immunology)
[2018, 50:55-59]

Cited: 3 times

View full text PDF listing >>



Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease.

Peter Faries, Michael Jaff, Patrick Peeters, Yazan Khatib, David Roberts, Marc Bosiers, Rajesh Malik, Reid Ravin, John Rundback,

<h4>Background</h4>The DURABILITY Iliac clinical study evaluated the safety and effectiveness of 2 nitinol self-expanding stents for the treatment of atherosclerotic common and external iliac artery lesions up to 10 cm in length and >50% stenosis in subjects with Rutherford classification peripheral arterial disease stages 2-4.<h4>Methods</h4>DURABILITY Iliac was a prospective, multicenter, core ... Read more >>

Ann Vasc Surg (Annals of vascular surgery)
[2018, 51:37-47]

Cited: 0 times

View full text PDF listing >>



Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.

Antonio Micari, Marianne Brodmann, Koen Keirse, Patrick Peeters, Gunnar Tepe, Martin Frost, Hong Wang, Thomas Zeller, ,

OBJECTIVES:The IN.PACT Global Study is the largest prospective, multicenter, independently adjudicated trial to evaluate a paclitaxel drug-coated balloon in patients with lifestyle-limiting claudication and/or ischemic rest pain due to atherosclerotic disease of the femoropopliteal artery and includes complex lesions beyond what are typically included in randomized controlled trials. BACKGROUND:Randomized controlled ... Read more >>

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2018, 11(10):945-953]

Cited: 13 times

View full text PDF listing >>



Facing a New Face: An Interpretative Phenomenological Analysis of the Experiences of a Blind Face Transplant Patient and His Partner.

Hannelore Hendrickx, Phillip N Blondeel, Hanna Van Parys, Nathalie A Roche, Patrick C Peeters, Hubert F Vermeersch, Xavier Rogiers, Kristiane Van Lierde, Gilbert M D Lemmens,

Increasing evidence points to good functional, aesthetic, and psychosocial outcomes after face transplantation. However, research investigating how patients and their families subjectively experience the transplantation process is lacking thus far. This study aims to investigate the personal experiences of a blind face transplant patient and his partner. In-depth interviews exploring ... Read more >>

J Craniofac Surg (The Journal of craniofacial surgery)
[2018, 29(4):826-831]

Cited: 0 times

View full text PDF listing >>



Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.

Herman Schroë, Andrew H Holden, Yann Goueffic, Shirley J Jansen, Patrick Peeters, Koen Keirse, Wulf Ito, Frank Vermassen, Antonio Micari, Erwin Blessing, Michael R Jaff, Thomas Zeller,

<h4>Objectives</h4>The purpose of this study was to assess the safety and performance of Stellarex Drug-coated balloon (DCB).<h4>Background</h4>DCB coatings differ in excipients, paclitaxel dose, and coating morphologies. Due to these differences, a class effect with DCBs has not been demonstrated. Consequently, each DCB needs to be evaluated independently based on its ... Read more >>

Catheter Cardiovasc Interv (Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions)
[2018, 91(3):497-504]

Cited: 9 times

View full text PDF listing >>



Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.

Thomas Zeller, Ralf Langhoff, Krishna J Rocha-Singh, Michael R Jaff, Erwin Blessing, Beatrice Amann-Vesti, Marek Krzanowski, Patrick Peeters, Dierk Scheinert, Giovanni Torsello, Sebastian Sixt, Gunnar Tepe, ,

<h4>Background</h4>Studies assessing drug-coated balloons (DCB) for the treatment of femoropopliteal artery disease are encouraging. However, challenging lesions, such as severely calcified, remain difficult to treat with DCB alone. Vessel preparation with directional atherectomy (DA) potentially improves outcomes of DCB.<h4>Methods and results</h4>DEFINITIVE AR study (Directional Atherectomy Followed by a Paclitaxel-Coated Balloon ... Read more >>

Circ Cardiovasc Interv (Circulation. Cardiovascular interventions)
[2017, 10(9):]

Cited: 23 times

View full text PDF listing >>



Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome.

Kathleen J Claes, Annick Massart, Laure Collard, Laurent Weekers, Eric Goffin, Jean-Michel Pochet, Karin Dahan, Johann Morelle, Brigitte Adams, Nilufer Broeders, Patrick Stordeur, Daniel Abramowicz, Jean-Louis Bosmans, Koen Van Hoeck, Peter Janssens, Lissa Pipeleers, Patrick Peeters, Steven Van Laecke, Elena Levtchenko, Ben Sprangers, Lambertus van den Heuvel, Nathalie Godefroid, Johan Van de Walle,

Acta Clin Belg (Acta clinica Belgica)
[2018, 73(1):80-89]

Cited: 3 times

View full text PDF listing >>



Advertisement


Disclaimer

1.1615 s